Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Danvers is a holding company for banks in Massachusetts, with 25 branches. The company's has $2.5 billion in assets and provides traditional banking services and non-deposit investment products and services.
Another Beat
On Jul 22 Danvers saw net income for the second quarter rise to $4.9 million, from $0.14 million a year ago. Deposits were up 15% on an annualized basis. Net interest income was up 62% as the loan portfolio grew along with margins.
Earnings per share came out to 24 cents, which was 5 cents higher that analysts were expecting. Danvers has now beaten the Zacks Consensus Estimate in each of the past 4 quarters.
While the company did say there could be challenges to keep the loan portfolio growing, they hope to be back to their "historic rates" this year.
Consensus is Rising
Analysts were quick to raise their full-year projections following the quarterly release. The Zacks Consensus Estimate for this year is up a nickel to 82 cents. Next year's estimates are averaging 92 cents, up 4 cents.
Last year Danvers only made 31 cents, so the growth rates are now expected to be 166% and 12%, respectively.
The Chart
Shares of DNBK broke through recent resistance on the earnings news and are now approaching the 52-week high.